Von Willebrand factor ristocetin cofactor (VWF:RCo) assay: Implementation on an automated coagulometer (ACL)

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 12, 2005, Pages 2684-2688

  Redaelli, R ^a,b   Corno, A R ^a   Borroni, L ^a   Mostarda, G ^a   Nichelatti, M ^a   Morra, E ^a   Baudo, F ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Automated assay; Von Willebrand disease; Von Willebrand factor RCo assay

Indexed keywords

BILIRUBIN; HEMOGLOBIN; RISTOCETIN; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ACCURACY; ARTICLE; ASSAY; AUTOMATION; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

AUTOMATION; BILIRUBIN; BLOOD COAGULATION TESTS; HEMOGLOBINS; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 29244472479     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01628.x     Document Type: Article

References (17)

1. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, Meyer D, Peake I, Rodeghiero F, Srivastava A. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
2. Mendolicchio GL, Ruggeri ZM. New perspectives on von Willebrand Factor functions in hemostasis and thrombosis. Semin Hematol 2005; 42: 5-14.
3. Schneppenheim R. The evolving classification of von Willebrand disease. Blood Coagul Fibrinolysis 2005; 16 (Suppl. 1): S3-S10.
4. Budde U, Drewke E, Mainusch K, Schneppenheim R. Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost 2002; 28: 173-89.
5. Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003; 88: 94-108.
6. Lillicrap D. World Federation of Hemophilia Editor. The basic science, diagnosis and clinical management of Von Willebrand disease. Treatment of Hemophilia Monographs 2004; 35: 1-11. Available at http://www.wfh.org.
7. Mac Farlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-8.
8. Favaloro EJ, Thom J, Baker R. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey. Blood Coagul Fibrinolysis 2000; 11: 729-37.
9. Miller CH, Platt SJ, Daniele C, Kaczor D. Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand Factor. Thromb Haemost 2002; 88: 56-9.
10. Lindahl TL, Faderberg IH, Larsson A. A new cytometric method for measurement of von Willebrand factor activity. Scand J Clin Lab Invest 2003; 63: 217-24.
11. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-3.
12. National Committee for Clinical Laboratory Standards. Assays of von Willebrand Factor Antigen and Ristocetin Cofactor Activity; Approved Guideline, NCCLS Document H51-A; Vol. 22, No. 20.
13. Martin RF. General Deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clin Chem 2000; 46: 100-4.
14. Combleet PJ, Gochman N. Incorrect least-squares regression coefficients in method-comparison analysis. Clin Chem 1979; 25: 432-8.
15. Quenouille MH. Approximate tests of correlation in time series. J Royal Stat Soc B 1949; 11: 18-44.
16. Quenouille MH. Notes on bias in estimation. Biometrika 1956; 61: 353-60.
17. Favaloro EJ, Grispo L, Dinale A, Berndt M, Koutts J. Von Willebrand disease: laboratory investigation using an improved functional assay for von Willebrand Factor. Pathology 1993; 25: 152-8.